Wells Fargo Maintains Overweight on Agilon Health, Raises Price Target to $170

Benzinga · 20h ago
Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and raises the price target from $146 to $170.